ATTENTION: For additional congress contributions please refer to the videos:
http://www.sigmund-silber.com/cms/deutsch/videos

91st Annual Meeting of the German Society of Cardiology (DGK)
April 24, 2025
Chairmanship and Summary
How Will CT Coronary Angiography (CCTA) Change Cardiology in the Future?
Program

30th Dresden Symposium
November 22 – 23, 2024, Dresden
Lecture
Exclusion of CHD With Positive Ischemia Detection – False Positive or INOCA? What to Do?
Program

12th Update for the General Practice in Deggendorf
September 21, 2024, Deggendorf
Lipid Management: Control Blood Lipids – Stop Arterial Calcification
Heart Failure: New and Proven
Program

Continuing Education Forum for General Medicine
June 29, 2024, Wiesbaden
Angina Pectoris – but in the Cath Lab “Exclusion of CHD”: What Now?
Program

90th Annual Meeting of the German Society of Cardiology (DGK)
April 4, 2024
Chairmanship and Summary
To What Extent Has Artificial Intelligence (AI) Already Changed Image Interpretation in Cardiology Today? – Where Is the Journey Going?
Program
Summary Presentation

12th Update for the General Practice in Munich
November 18, 2023
Lecture
DMP: Modern Diagnostics and Therapy of Heart Failure Including Cardiac Amyloidosis
Program
Video of the Entire Lecture

89th Annual Meeting of the German Society of Cardiology (DGK)
April 12, 2023
Chairmanship and Introduction
Exclusion of CHD With Positive Imaging-Based Ischemia: False Positive or INOCA?
Program
Lecture for Introduction

SMART HEART Continuing Education: Heart Failure Therapy Distilled Lecture and Moderation
“What May I Do? What May I Not? – Health-Economic Aspects
October 13, 2022
Munich, Smart Village, Ganghoferstr. 66b
Program

Continuing Education for General Practices:
Heart Failure Is Not a Diagnosis – How Intensively Must Diagnostics and Therapy Be Pursued?
October 5, 2022
Chairmanship and Lecture Munich, Leonardo Royal Hotel, Moosacherstr. 90
Program

15th Course for Cardiovascular Nuclear Medicine / Nuclear Cardiology
September 15, 2022
Chairmanship and Lecture The ISCHEMIA Study: Impact on Revascularization
Program

Cardio-Expert Meeting
June 18, 2022 Berlin – Andel’s Berlin Vienna House
Lecture What May I Do? What May I Not? Health Economy in Focus – as a Statutory Health Insurance Physician
Program Video of the Lecture

1st KITZINGER CARDIOVASCULAR SYMPOSIUM
April 30, 2022
Lecture: Intersectoral Care and Transfer Into Practice Using the Examples of DMP, ASV and TMZ
Program

88th Annual Meeting of the German Society of Cardiology (DGK)
April 22, 2022
Chairmanship and Summary Noninvasive Imaging-Based Ischemia Diagnostics of the Heart With Regadenoson
Program

88th Annual Meeting of the German Society of Cardiology (DGK) April 20, 2022 General Assembly of the Working Group Nuclear Cardiology
Lecture The Role of Nuclear Cardiology in the Cardiology Training Regulations: Current Status and Potential Future Developments
Program

27th Dresden Symposium November 20, 2021 Dresden, Ramada by Wyndham Hotel
Lecture CT, Stress Echo, SPECT, PET or MRI in Chest Pain – When Do I Use Which Modality?
Program

22nd International Cardiology Symposium
October 30, 2021 Düsseldorf
Lecture Antiplatelet Therapy in CHD: De-Escalation or Escalation?
Program Lecture as Video

10th Update for the General Practice
October 16, 2021 Munich, Rilano Hotel
Lecture New European Guidelines for Patients With Heart Failure: What Changes for General Practice?
Program

Heart Cinema – Play Me the Song of Death
September 22, 2021 Drive-In Cinema Aschheim near Munich
Scientific Direction and Lecture “Mission Impossible”
Program Trailer for Announcement Lecture and Discussion by Prof. Silber “The Weak Heart”

3rd Cardiology Autumn Forum
September 18, 2021 Nuremberg MÖVENPICK Conference Center Nuremberg Airport
Antithrombotic Therapy in Coronary Heart Disease: What, With Whom, How Long?
Program Video of the Lecture

Shanghai International Symposium on Medicine in the 21st Century
September 17, 2021
Lecture – Keynote Lecture Highs and Lows in the History of PCI – My Personal Experience
Program Lecture as Video

Cardio-Expert Meeting
September 11, 2021 Berlin – Hotel am Gendarmenmarkt
Workshop Lecture The DMP Heart Failure
Program

Continuing Education of Greek Physicians in Munich (IATRIKI-MUC)
June 30, 2021
Lecture Corona and the Heart
Program Video of the Lecture

87th Annual Meeting of the German Society of Cardiology (DGK)
April 7, 2021
Chairmanship and Summary: Multimodal Cardiac Imaging – Nuclear Cardiology and Beyond
April 9, 2021
Chairmanship and Introduction: The New DMP Heart Failure: Progress or Regress?

Annual Meeting of the ESC (European Society of Cardiology)
Amsterdam – August 29, 2020 Held Virtually Due to “Corona”
Usefulness of the Coronary Artery Calcium (CAC) Score for Statin Prescription in Primary Prevention: Results in Over 16,000 Assessments
M. Keller, S. Silber
Abstract Program Lecture as Video (In English, Duration: 4:55)

Annual Meeting of the ESC (European Society of Cardiology)
Amsterdam – August 29, 2020 Held Virtually Due to “Corona”
Pharmacological Stress Test With Regadenoson When Adenosine Is Contraindicated: Prospective Documentation of Side Effects in Over 700 Patients With COPD or Bronchial Asthma
M. Keller, M. Rippel, S. Silber Poster

Forssmann Symposium 2019 – 90 Years After the Self-Experiment
Lecture: Interventional Cardiology of the Coronary Arteries (PCI): Yesterday – Today – Tomorrow
Eberswalde, Haus Schwärzetal, November 8, 2019

Expert Discussion Munich Scientific Direction
Munich, Maritim Hotel, October 23, 2019

TCT Congress, San Francisco, California Various Chairmanships and Moderations
September 25 – 29, 2019

48th Conference of the Professional Association of German Nuclear Medicine Specialists (BDN) Nuclear Cardiology From the Heart’s Depths
Lecture: Pharmacological Stress Tests: Experience in a Cardiology Practice
Berlin, Pullman Berlin Schweizerhof, September 20, 2019

14th Course for Cardiovascular Nuclear Medicine / Nuclear Cardiology
Lecture: The New ESC 2019 Guidelines for Management of Chronic Coronary Syndrome (CCS): What Does Invasive Cardiology Need to Know From Nuclear Cardiology?
Potsdam, Inselhotel, September 14, 2019

Annual Meeting of the European Society of Cardiology (ESC)
Lectures:

1. Frail Patient With Coronary Heart Disease
2. Congress Condensed – Coronary Heart Disease

Paris, August 31 and September 4, 2019

15th Zweibrücken Symposium “Left and Right of Cardiology”
Lecture: News and Practice-Relevant Insights From ACC 2019
Nardini Clinic, Zweibrücken, May 25, 2019

85th Annual Meeting of the German Society of Cardiology – Heart and Circulatory Research (DGK) Mannheim, April 24 and 25, 2019

• Lecture by Prof. Silber: Regadenoson for Pharmacological Stress Testing in Myocardial Scintigraphy Program
• Lecture (Keynote Session) M. Keller, P. Styllou, S. Silber: The New US Guidelines for Statin Therapy and Determination of the Coronary Calcium Score in Primary Prevention: An Analysis of Over 12,000 Individuals Program Scientific Abstract
• Chairmanship and Introduction by Prof. Silber: Noninvasive Ischemia Quantification and Viability Detection: What Is Relevant for the Decision on Myocardial Revascularization in Light of the New ESC Guidelines? Program

Spotlight Lipids Munich, Marriott Hotel, March 30, 2019
Interdisciplinary Congress Update ACC: Cross-Indication Outlook on Therapeutic Developments
Program

9th Cardiology Symposium Bad Griesbach, March 23, 2019
Guidelines on Myocardial Revascularization Including Dual Antithrombotic Therapy
Program

68th Annual Meeting of the American College of Cardiology (ACC) New Orleans, March 16, 2019 Poster, S. Silber, M. Rippel, M. Keller:
Regadenoson for Pharmacological Stress Tests: Blood Pressure, Heart Rate and Major Side Effects in 5780 Patients Referred for Myocardial Scintigraphy. A High-Volume Single-Center Experience
Program Abstract Poster

Continuing Education Event Diabetes, CHD and Heart Failure Munich, February 2, 2019 Klinikum Rechts der Isar Lecture by Prof. Silber:
Still High Mortality Rates in Type 1 Diabetes With Early Onset: New Targets for Cardioprotection?
Program

11th pci.live Congress Munich, November 28 – 29, 2018
Program All Presentations

24th Dresden Symposium “Heart and Vessels – Innovations 2018” Dresden, November 24, 2018 Lecture by Prof. Silber:
ESC Guideline on Myocardial Revascularization 2018 – What Is Really New?
Program

“Herztage” of the DGK (German Society of Cardiology) Berlin, October 11 – 13, 2018

• Chairmanship and Introduction: Fundamentals of Imaging Procedures in CHD Diagnostics for the Cardiology Exam (Cluster Imaging Procedures)
• Poster (P. Styllou and S. Silber): Program Scientific Abstract
• Poster: Distribution of Coronary Artery Calcification in a Cardiology Practice Population of Over 13,000 Patients in Germany. Do We Need to Adjust Thresholds for Pharmacological Prevention?

TCT Congress, San Diego, California, USA September 21 – 25, 2018
Various Chairmanships and Lectures (Overview)

• Poster Presentation: Five Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

19th International Cardiology Symposium – Meet The Experts Düsseldorf, September 15, 2018 Chairmanship and Lecture by Prof. Silber:
Triple Therapy After PCI in AF Patients: An Individualized Decision or Already Obsolete?
Program

European Society of Cardiology (ESC) Munich, August 29, 2018 Lecture by Prof. Silber
Congress Condensed: Coronary Heart Disease
Program

European Society of Cardiology (ESC) Munich, August 25, 2018 Best Poster: M. Keller, M. Rippel, S. Silber:
Side Effects of Regadenoson Replacing Adenosine for Pharmacological Stress Tests in the Real World: Prospective Evaluation in Over 5000 Patients

• Abstract
• Program
• Poster

Practice Anticoagulation Forum Munich, July 14, 2018 Scientific Leadership
Program

Rosenheim Cardiology Days Rosenheim, June 30, 2018 Lecture by Prof. Silber
CHD in Atrial Fibrillation: Is Triple Therapy After Stent Implantation Obsolete?
Program

“Great Minds” European PCI Expert Meeting Vienna, June 15, 2018 Lecture by Prof. Silber:
Short DAPT Case
Program

May Continuing Education 2018 Altötting, May 2, 2018 Medical Clinics of the District Hospitals Altötting-Burghausen Lecture by Prof. Silber:
Atrial Fibrillation and Coronary Stents: End of Triple Therapy? DAPT How Long?
Program

German Society of Internal Medicine (DGIM) Mannheim, April 16, 2018 Chairmanship and Discussion by Prof. Silber:
Lipid Management Solved? PCSK9 Inhibitors – A Sustainable Approach in Secondary Prevention
Program Press Report

Annual Meeting of the German Society of Cardiology (DGK) Mannheim, April 4, 2018 Lecture by Prof. Silber:
Imaging Prior to Atrial Fibrillation Ablation – What Is Established, What Is New, What Is Obsolete? Introduction to the Topic
Program Cluster “Imaging Procedures”

American College of Cardiology (ACC) Orlando, March 11, 2018
IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS JACC March 20, 2018 Volume 71, Issue 11
Abstract Poster

10th German Cardio Diagnostics Days Leipzig, February 23, 2018 Congress Hall Lecture by Prof. Silber:
Regadenoson in Ischemia Diagnostics – Experience in Over 5000 Patients in a Cardiology Practice
Program

8th Cardiology Symposium Bad Griesbach, March 3, 2018 Lecture by Prof. Silber:
Dual Therapy or Triple Therapy After Coronary Stent Implantation?
Program

18th Annual Meeting of NFIC (New Frontiers in Interventional Cardiology) Krakow, December 7 and 8, 2017 Chairmanships and Lecture by Prof. Silber:
Usefulness of Pharmacological Stress Tests With Regadenoson: Experience in Over 4000 Patients in a Cardiology Practice in Germany.
Program Letter of Appreciation

Cardiology Training Seminars Schloss Wilhelminenberg (Vienna), December 2, 2017 Lecture by Prof. Silber:
Does the Coronary Calcium Score Provide Additional Information to Estimate Cardiac Risk?
Program

10th pci-live Congress, Haus der Kunst, Munich November 30 and December 1, 2017 Lectures by Prof. Silber:

• Is Triple Therapy Obsolete?
• Latest TCT Studies on DAPT Duration After Stent Implantation/ACS: Are the ESC DAPT Guidelines of August 2017 Already Outdated?

Program

Annual Meeting of CIAT (Cardiovascular Intervention Association of Thailand) Bangkok, November 18, 2017 Lecture by Prof. Silber:
Should All DAPTs Post PCI Be New P2Y12?
Program

TCT Congress, Denver, Colorado October 29 – November 2, 2017 Chairmanships and Lecture by Prof. Silber:
Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective
Program

Heart Failure Roundtable Berlin, October 12, 2017 Chairmanship and Lecture by Prof. Silber:
Heart Failure – Introduction to the Topic
Program

Current Developments in Cardiology Düsseldorf, September 23, 2017 Chairmanship and Lecture by Prof. Silber:
Secondary Prevention After ACS With Antiplatelet Agents in the Long Term (1–4 Years); How Would You Decide? Interactive Case Discussion
Program

Annual Meeting of the European Society of Cardiology (ESC) Barcelona, August 30, 2017 Lecture by Prof. Silber:
Congress Condensed – General Cardiology Coronary Artery Disease
Program

Munich Medical Day Clinic and Polyclinic for Psychiatry and Psychotherapy, Lecture Hall 124 Nußbaumstr. 7 Munich, September 16, 2017 Lecture by Prof. Silber:
Antiplatelet Therapy in CHD: What Must the General Practitioner Know From the Current Data Jungle?
Program

Munich Heart Congress Munich, Literaturhaus, September 16, 2017 Panel and Lecture by Prof. Silber:
Antiplatelet Therapy After Coronary Stent Implantation: With What? How Long? Are Bare Metal Stents Still Indicated? Is Triple Therapy Obsolete?
Program

Cardio-Workshop Munich, July 5, 2017 Scientific Direction and Lecture by Prof. Silber:
Scientific Basics and Updates in the Therapy of Acute Coronary Syndrome: Dual Antiplatelet Therapy in High-Risk Patients Beyond 12 Months?
Program

Practice Anticoagulation Forum Munich, July 1, 2017 Scientific Direction: Prof. Silber
Program

Hyperlipidemia Update Munich, June 28, 2017 Scientific Direction: Prof. Silber
Program

Great Minds – Expert Meeting Budapest, June 23, 2017 Lecture by Prof. Silber:
Old and New Effective Strategies for LDL-Cholesterol Reduction
Program Video of the Lecture (In English, Duration: 18:46)

EuroPCR Congress Paris, May 17, 2017 Poster Presentation: Okada K, Cutlip D.E., Barakat M, Silber S, Erglis A, Honda Y on behalf of the COBRA PzF SHIELD Investigators
Final Optical Coherence Tomography Results From the COBRA PzF SHIELD Trial
Poster

International Conference on Nuclear Cardiology and Cardiac CT (ICNC) Vienna, May 9, 2017 Poster Presentation: Dr. med. M. Keller and Prof. Dr. S. Silber:
High Safety of Regadenoson for Myocardial Perfusion Imaging in a Cardiology Practice: Experience in Over 4000 Patients
Poster

123rd Annual Meeting of the German Society of Internal Medicine (DGIM) Mannheim, May 1, 2017 Expert Forum Lecture by Prof. Silber:
Antiplatelet Agents in CHD: Which One? How Long?
Program

DIABETES 2017: Interface of Metabolism and Cardiovascular Risk Munich, Klinikum Rechts der Isar, April 26, 2017 Lecture by Prof. Silber:
Are Antidiabetic Drugs Now “Cardiologic”?
Program

Patient-Centered Anticoagulation in Clinical Practice: Munich, Municon, February 14, 2017 Lecture by Prof. Silber:
Which NOAC for Which Patient?
Program

Heart Failure Bavaria Congress, Würzburg 3rd Network Meeting, January 25, 2017
Lecture by Prof. Silber: The New DMP Heart Failure and HeartCareBavaria
Program

pci-live Congress, Haus der Kunst, Munich December 2, 2016

• Lecture by Prof. Silber: How Much Diabetology Is Needed in Cardiology? (In German, Duration: 13:07)
  • Lecture as PPT file (14 MB)

pci-live Congress, Haus der Kunst, Munich December 1, 2016

• Lecture by Prof. Silber: Secondary Prevention With Extended DAPT (In German, Duration: 17:06)
  • Lecture as PPT file (21 MB)
• Discussion of the Lecture: (In German, Duration: 3:55)

TCT Congress, Washington, DC November 1, 2016
Lecture by Prof. Silber: Didactic Session: The TCT Late Breaking Trials: Highlights – and My Interpretations – From: BIO-RESORT (TWENTE III) and BIONICS (Lecture in Original Sound, in English, Duration: 7:34)

• Lecture as PPT file (8 MB)
• Discussion of the Lecture: (In English, Duration: 12:54)

TCT Congress, Washington, DC October 31, 2016
Lecture by Prof. Silber: Can Passive Coatings Make a Difference? Results With the COBRA PzF NanoCoated Coronary Stent (PPT file, 3.5 MB)
Lecture as Video in English (Duration: 6:45)

Munich Heart 2016
Lecture: Dual Antiplatelet Therapy (DAPT) After Coronary Stent Implantation: With What? How Long Is Optimal – Weeks or Years?
Munich, September 10, 2016

ESC Congress (European Society of Cardiology) Rome, August 2016
Lecture: Nightmares in Clinical Practice: To Stop or Not to Stop Antiaggregation and/or Anticoagulation Before a Procedure Video of the Lecture (In English, Duration: 19:22)
Lecture: Take Home Message for the Practitioner: Coronary Heart Disease Video of the Lecture (In English, Duration: 10:46)
Poster: R. Piccolo, A. Franzone, K. Koskinas, L. Raeber, T. Pilgrim, M. Valgimigli, S. Stortecky, J. Rat-Wirtzler, S. Silber, P. Juni, D. Heg, S. Windecker Diabetes and Time Course of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Rosenheim Cardiology Days
Lecture: Therapy of Stable CHD 2016 – Medications vs. Revascularization: The Current National Care Guideline
Rosenheim, July 2, 2016

Case Workshop: Risks in Interventional Cardiology
Lecture: Pitfalls in ACS Patients – Recognition and Treatment
Eberswalde / Werbellinsee, June 22, 2016

Munich Medical Day
Lecture: NOACs – Are There Differences? Summary
Munich, June 18, 2016

Annual Meeting of the German Society of Internal Medicine (DGIM)
Lecture: National Care Guidelines: CHD From the Cardiologist’s View
Mannheim, April 9, 2016

Annual Meeting of the German Society of Cardiology (DGK) J.-N. Boeckel, L. Palapies, J. Klotsche, T. Zeller, B. von Jeisen, L. Pieper, S. Tzikas, D. Leistner, C. Bickel, G. K. Stalla, H. Lehnert, S. Silber, S. Baldus, W. März, S. Dimmeler, S. Blankenberg, T. Münzel, A. M. Zeiher, T. Keller
Lecture: A New Method to Adjust Troponin I Accounting for the Confounders Age, Gender and Kidney Function Facilitates Clinical Interpretation in Patients With Chest Pain
Mannheim, April 2, 2016

Congress: “Diabetology Without Borders”
Lecture: Current Cardiovascular Outcome Studies – Implications for Diabetes Therapy… …From the Cardiologist’s Perspective
Unterschleißheim, February 19, 2016

pci-live Congress, Haus der Kunst, Munich

• Congress Trailer (Duration: 1:00)

1. December 2, 2015 Introduction and Concept, Prof. Silber (in German, Duration: 3:14)
2. December 3, 2015 Lecture Prof. Silber: Real-world use of NOACs: nuances of triple therapy – with what? for how long? (in German, Duration: 25:05)

• Lecture as PPT file (20 MB)

Munich Medical Day
Lecture:Dual antiplatelet therapy in CHD: end of standardized treatment? Chair
Munich, September 26, 2015

Workshop Stroke Prophylaxis in Atrial Fibrillation: Oral Anticoagulants in Transition
Lecture: Overview of current anticoagulants: guideline recommendations
Munich, September 15, 2015

ESC Congress (European Society of Cardiology) Piccolo R, Heg D, Rat, Franzone JA, Silber S, Serruys PW, Pigrim T, Juni P, Windecker S.
Comparative effectiveness and safety of new versus early-generation drug-eluting stents according to the complexity of coronary artery disease: A patient-level pooled analysis of 6,081 patients
download presentation download abstract, European Heart Journal (2015) 36 (Abstract Supplement), 29
London, August 29, 2015

4th National TAVI User Meeting (Certificate of Attendance)
Munich, June 26, 2015

Workshop Medicine and Law: Law and Risks in Interventional Cardiology
Lecture: Pitfalls in Antiplatelet Therapy
Eberswalde, June 12, 2015

Workshop Medicine and Law: Law and Risks in Interventional Cardiology
Lecture:Pitfalls in Antiplatelet Therapy
Dresden, June 10, 2015

Hannover Heart Fair 2015
Lecture:Which strategies save lives in acute myocardial infarction?
Hannover, May 9, 2015

Atrial fibrillation and thromboembolic events
Lecture:When and with what to anticoagulate in atrial fibrillation?
Munich, May 6, 2015

ICNC Congress: Nuclear Cardiology and CT
Practical experience and side effects of Regadenoson in myocardial radionuclide perfusion imaging in over 2,000 patients in a cardiology practice
Madrid, May 5, 2015

Workshop Medicine and Law: Law and Risks in Interventional Cardiology
Lecture:Pitfalls in Antiplatelet Therapy
Munich, April 29, 2015

Update in Cardiology
Lecture:2014 ESC/EACTS Guidelines in myocardial revascularization: what has changed?
Bucharest, April 18, 2015

ACC 2015
Lecture: No role for GPIIb/IIIa in the contemporary era: guidelines should be revised.
San Diego, March 16, 2015

Internal Medicine Interdisciplinary – Diabetology Without Borders
Chair:Diabetes and Interventional Cardiology Lecture:Diabetes and CHD: When to remain conservative, when interventional or surgical?
Unterschleißheim, February 28, 2015

New Developments in Cardiology and Cardiac Surgery – Case Studies and Overview Lectures
Chair:Focus Coronary Arteries
Munich, January 24, 2015

11th OGN Congress
Lecture:Rapiscan – Experiences in Everyday Nuclear Cardiology Practice
Zell am See, Austria, January 22, 2015

p-c-i live Congress
Symposium: Secondary prevention after ACS – role of DOACs Chair
Munich, December 5, 2014

p-c-i-Live Congress
Scientific Direction
Munich, December 3–5, 2014

2014 – Autumn Meeting and Annual Meeting of the Working Group on Rhythmology of the German Cardiac Society – Heart and Circulation Research e.V.
Discussion Leader
Düsseldorf, October 11, 2014

Continuing education:
Interactive case discussion: Patients with unclear thoracic and/or abdominal complaints: how would you proceed? Speaker
Munich, September 24, 2014

Munich Medical Days:
Lecture:Atrial fibrillation, stroke and myocardial infarction – new paths in antithrombotic therapy Chair
Munich, September 20, 2014

ESC Congress:
Lecture: Take-home message – Coronary artery disease update 2014
Barcelona, August 30, 2014

Rosenheim Cardiology Days:
Lecture: Dual antiplatelet therapy in CHD – current status, duration, with what?
Rosenheim, July 12, 2014

New Aspects of Oral Anticoagulation in the Tension Between Guidelines and Cost-Effectiveness
Lecture: Long-term secondary prophylaxis after ACS with Rivaroxaban? – New guidelines on triple therapy
Dr. Müller Clinic, Munich, July 9, 2014

3rd National TAVI User Meeting (Certificate of Attendance)
Nyon, Switzerland, July 4, 2014

Current Topics in Cardiology in Dialogue:
Lecture:PCI and antithrombotic therapy of acute coronary syndrome – all questions answered?
Cologne, June 25, 2014

Medical Continuing Education Event:
Lecture:Clinical value of ischemia detection to avoid unnecessary cardiac catheterizations and stent implantations
Munich, May 28, 2014

17th Spring Meeting, Heart Center Leipzig:
Conservative and interventional treatment strategies Lecture:When and which antiplatelet inhibitor in STEMI and NSTEMI
Leipzig, May 9, 2014

120th Congress of the German Society of Internal Medicine:
Chair:Ischemia diagnostics in CHD: Myocardial scintigraphy avoids unnecessary cardiac catheterizations and stent implantations Lecture: Clinical value of non-invasive and invasive ischemia detection from a cardiological perspective
Wiesbaden, April 26, 2014

Congress: Heart Update
Lecture: Differentiated antiplatelet therapy after interventional procedures: what to do if surgery becomes necessary (bridging)?
Bremen, March 2014

43rd Annual Meeting of the German Society for Thoracic, Cardiac & Vascular Surgery
Lecture:EACTS/ESC revascularization guidelines
Freiburg, February 9, 2014

Lecture: Dr. Müller Clinic
Presentation of the new CPU and treatment pathways in ACS
Munich, January 29, 2014

p-c-i Live 2013
Congress Direction
Munich, November 28–29, 2013

Continuing education event: Chest Pain Unit – Highlights and Everyday Practice
Lecture:Acute coronary syndrome – always cardiac catheter?
Munich, November 25, 2013

9th Asian Interventional Cardiovascular Therapeutics (AICT 2013)
Faculty Member
Bangkok, Thailand, November 14–16, 2013

Fajadet J, Garcia E, Neumann FJ, Hildick-Smith D, Petronio S, Spence M, Wöhrle J, Zaman A, Elhadad S, Silber S on behalf of the Platinum Plus Trial Investigators
Results of the Primary Endpoint of the Platinum Plus Trial: A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients – 1-Year Results TCT (Transcatheter Cardiovascular Therapeutics)
San Francisco, October 2013
PowerPoint Presentation

Lectures at TCT 2013

• p-c-i live partnership session@TCT
• The Case for Prasugrel
• all lectures

San Francisco, USA, October 27–31, 2013

2013 Autumn and Annual Meeting of the Working Group Electrophysiology of the German Cardiac Society – Heart and Circulation Research:
Chair:Symposium: Interventional therapy of ACS – which patient benefits when from dual antiplatelet therapy?
Dresden, October 11, 2013

Training: New Platelet Inhibitors and New Anticoagulants:
Reduction of ischemic events at the cost of increased bleeding? Practical Recommendations Lecture: Problems from a cardiological perspective
Munich, October 9, 2013

Continuing education event: “The cardiological case”
Lecture:Case 1 Acute coronary syndrome – what do the new guidelines tell us? Interventional revascularization and antithrombotic medication
Munich, September 25, 2013

ESC 2013

• Lecture:Coronary Artery Disease – Update 2013
• Chair:Surgical revascularization: refining the outcomes

Amsterdam, August 31 – September 4, 2013

Symposium: ThromboVision: New Perspectives in Anticoagulation
Lecture: Therapy options in ACS: What should one know today?
Berlin, Estrel Hotel, June 15, 2013

Symposium: Atrial Fibrillation, Stroke and Myocardial Infarction: The new medications: better – or just more expensive?
Lecture: Can we afford to implement current guidelines?
Munich, June 13, 2013

Symposium: TCT Russia and XV Moscow’s International Course on Endovascular Therapies Lectures: Coronary Artery Disease in diabetic patients: Complexities and Clinical Evidence”. Which DES to choose for diabetic patients?
The re-emergence of local drug delivery: drug coated balloons Introduction DES with Biodegradable Polymer
Evidence based device selection (stents, thrombectomy, etc.) for primary PCI POBA, BMS, DES, BVS, DCB: practical guide to coronary device selection in 2013
Moscow, Renaissance Moscow Monarch Centre Hotel, June 8–11, 2013

16th Spring Meeting Heart Center Leipzig Lectures:

• The stent of the future
• Dual antiplatelet therapy during and after ACS – When Clopidogrel? – When Prasugrel? – When Ticagrelor?

Leipzig, May 3, 2013

Hannover Heart Fair 2013 Lectures:

• ACS therapy after hospital from the perspective of the outpatient cardiologist
• Platelet inhibitors in/after ACS: Are the guidelines always practice-oriented?

Hannover, April 27, 2013

Edwards Transcatheter Heart Valve Training Program (Certificate of Completion)
Nyon, Switzerland, April 17/18, 2013

Training: Erlangen Cardio Symposium
Lecture: Interventional revascularization and subsequent platelet inhibition: What do the new guidelines tell us?
Erlangen, Arvena Hotel, March 20, 2013

INDIALIVE 2013:
Moderator:Complex PCI Symposium I Chairperson:Bifurcation
Chennai, India, February 28, 2013

Symposium: JIM – Joint Interventional Meeting Lectures:

• The RESOLUTE Program: today and tomorrow
• Novel stent design and Biomimicry in DES

Live Case Commentator: Live cases from Bonn, Germany
Rome, February 14–15, 2013

Training: Antiplatelet therapy in acute coronary syndrome (ACS)
Lecture: Antiplatelet therapy in ACS: From decision dilemma to rational therapy concept“
Continuing education event of the Ecumenical Association Hospital Location: Elisabeth Hospital
Trier, January 16, 2013

Congress: ICI (Innovations in Cardiovascular Innovations) Lectures:

• Ticagrelor or Prasugrel in ACS?
• Personalized Antiplatelet Therapy

Tel Aviv, December 3 and 4, 2012

p-c-i Live
Congress Direction Congress Opening Welcome Theme Block 4, Part B: Antiplatelet Therapy after Stent or Valve Replacement Moderation Live from all Centers: Live Case Results Report Theme Block 5: Atrial Fibrillation and Stroke Prophylaxis Part A: Pharmaceutical Options and Limits Moderation Multi-City Conference Berlin – Munich – Zurich Moderation Closing Address
Munich, November 29–30, 2012

Heart Days 2012
Master Course Cath Lab Welcome and Introduction to the Course
Munich, November 28, 2012

Prasugrel Investigator Masterclass:
What does the future bring? Chair Lecture: Congress Highlights 2012 FEATHER, TRIPLETT, GENERATIONS
Munich, November 24, 2012

Atrial fibrillation, stroke and myocardial infarction: updates on antithrombotic therapy for GPs and cardiologists Lecture:Antiplatelet therapy after stent implantation: Do we still need Clopidogrel?
Cardiological brunch
Altötting, November 17, 2012

Heart Week 2012
Heart in Danger: Recognizing and Treating Coronary Heart Disease Lecture:Risk factors, symptoms, stable angina pectoris and acute coronary syndrome – the emergency
Munich, November 14, 2012

Acute Coronary Syndrome: From Emergency Diagnosis to Aftercare Scientific Continuing Education Welcome and Introduction
Lecture: Myocardial infarction: All catheters? How to optimize aftercare?
Dr. Müller Clinic Munich, November 6, 2012

Fajadet J, Garcia E, Hildick-Smith D, Petronio S, Silber S, Neumann FJ, Zaman A, Wöhrle J, Spence M, Elhadad S on behalf of the Platinum Plus Trial Investigators
A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients: PLATiNUM PLUS – 1-Month Results TCT (Transcatheter Cardiovascular Therapeutics)
Miami, October 2012 Poster Presentation

Acute Coronary Syndrome: From Emergency Diagnosis to Aftercare Lecture:Myocardial infarction: All catheters? How to optimize aftercare?
Munich, October 8, 2012

New Paths in Antithrombotic Therapy: Atrial Fibrillation, Stroke and Myocardial Infarction – Current Guideline-Based Treatment Recommendations for GPs and Cardiologists
Lecture:Antithrombotic therapy: Do we need Clopidogrel?
Bayreuth, September 26, 2012

Symposium: Current Developments in Cardiology and Electrophysiology Chair: a new era of anticoagulation
Lecture: New options in anticoagulation after ACS
Düsseldorf, Intercontinental Hotel, September 15, 2012

Symposium: Atrial Fibrillation, Stroke and Myocardial Infarction: Updates on antithrombotic therapy for GPs and cardiologists
Lecture: Antiplatelet therapy after stent implantation
Weimar, September 12, 2012

Lecture: Cardiology Update for General Practitioners
Kloster Fraueninsel (Chiemsee), July 14, 2012

Symposium: Focus Cardiology Lecture:
Platelet inhibitors and coronary stents: Which stents? How long antiplatelet therapy?
University Hospital Regensburg, July 12, 2012

XXXIV Congresso DA SBHCI 2012
New frontiers – treatment of coronary artery disease with drug-coated balloon Lecture:Valentines Trial I: Is the drug-coated balloon an option to BMS and DES in intra-stent restenosis?
Salvador, Brazil, June 20, 2012

TCT Russia
Chair:Use of DES in Specific Clinical Scenarios Moderator: Thrombus Management in STEMI – MGuard™ Late-Breaking Data Moderator: Emerging Coronary Devices Lecture:Clinical update on Paclitaxel-coated balloon formulations: are there alternatives to iopromide-based coatings?
Moscow, Russia, May 28–30, 2012

118th Congress of the German Society of Internal Medicine:
Lecture:Optimal pharmacological lipid therapy in chronic CHD: the new national guidelines of the Federal Medical Association, the National Association of Statutory Health Insurance Physicians and the Association of the Scientific Medical Societies
Wiesbaden, April 16, 2012

78th Annual Meeting of the German Cardiac Society – Heart and Circulation Research e.V Symposium: 3 Years of Prasugrel – Experiences and Outlook
Lecture: Methodology of large studies on platelet inhibition and consequences for practice
Mannheim, April 11, 2012

Medical Continuing Education Event:
Lecture: Acute Coronary Syndrome: How long which antiplatelet inhibitors? – What must the GP consider?
Munich, March 29, 2012

Symposium: Current Cardiology and Angiology
Lecture: Antiplatelet Therapy in Atrial Fibrillation and ACS in Hospital and Practice
Neuburg Castle on the Kammel, Saturday, March 17, 2012

Third National Course on Percutaneous Cardiovascular Interventions Faculty Member
New Delhi, India, February 24–26, 2012

Symposium: JIM – Joint Interventional Meeting Live Case Commentator, Lectures:

• The use of new ADP inhibitors for treatment of ACS: reasons for choosing Prasugrel
• Performance of the Resolute Zotarolimus-eluting Stent for the Treatment of Total Occlusion

Rome, February 9–11, 2012

New Developments in Cardiology and Cardiac Surgery – Case Studies and Overview Lectures
Lecture: Prasugrel and Ticagrelor – and when still Clopidogrel?
Stiftsklinik Augustinum Munich, January 21, 2012

Acute Coronary Syndrome - what to do?
Current guideline-based treatment recommendations for general practitioners and cardiologists Lecture: Prehospital diagnosis and therapy of acute coronary syndrome today
Frankfurt am Main, December 14, 2011

ICI (Innovations in Cardiovascular Innovations) Presentations:

• The RESOLUTE Global Clinical Program with Focus on Patients with Diabetes Mellitus
• Evolution of Mitsu – Merilimus Eluting Coronary Stent System
• Drug-Eluting Balloons for In-Stent Restenosis after BMS or DES: State-of-the-Art Tel Aviv, December 5 and 6, 2011

p-c-i live
Congress Direction Congress Opening Welcome Session 1: Non-invasive Cardiac Imaging Moderation Evening Symposium 1: Antithrombotic/Antiplatelet Therapy with New Agents: Is measuring individual response to platelet aggregation inhibitors still up to date? Lecture 2 Session 4b: Coronary Revascularizations: Different Concepts for Bifurcations Chair TCT Symposium Highlights from TCT 2011 Moderation Closing Address
München, December 1 and 2, 2011

Acute Coronary Syndrome – what to do? New antithrombotic drugs: which benefit – which cost?
Lecture: Or rather Clopidogrel? And now the Atlas Study… consequences for practice
München, BMW-Welt, November 30, 2011

Hypertension: Heart under Pressure – Development – Detection – Treatment Heart Seminar for Patients, Relatives and Interested Parties
Lecture: Hypertension: detection, definition, causes, proper blood pressure measurement
München, November 19, 2011

TCT 2011, Special Twilight Session
Introduction of p-c-i live Lecture: PCI vs. Bypass Surgery: The European View: State of the Art
San Francisco, USA, November 10, 2011

From Research to Practice: Update Cardiology Workshop
Lecture: Acute Coronary Syndrome: how dangerous is it? what needs to be done? where to refer? optimal aftercare?
Bad Kohlgrub, October 22, 2011

Acute Coronary Syndrome - what to do?
Current guideline-based treatment recommendations for general practitioners and cardiologists Lecture: post-hospital: which long-term therapy is used in practice
Weimar, October 12, 2011

Herbsttagung der Deutschen Gesellschaft für Kardiologie-Herz- und Kreislaufforschung Symposium:
Modern platelet inhibition after ACS-PCI – hysteria or therapeutic necessity?
Presentation: Practical implementation: which agent – for whom – and for how long?
Düsseldorf, October 7, 2011

Training: Acute Coronary Syndrome – what to do?
Lecture: Which long-term therapy is used in practice?
Hannover, Loccumer Hof, September 28, 2011

Chiemgau Cardiology Days 2011 Chair
Lecture: Myocardial revascularization, time for an update? New data from ESC 2011
Gut Ising, September 17, 2011

Focus Cardiology Heart Failure and Acute Coronary Syndrome
Lecture: Acute Coronary Syndrome: prehospital: which immediate measures are necessary?
Regensburg, July 2, 2011

ACS MasterClass Munich:
Lecture: The 2010 ESC Guidelines on Myocardial Revascularization: A Critical Review
München, July 7, 2011

Acute Coronary Syndrome - what to do?
Lecture: post-hospital: which long-term therapy is used in practice?
Essen-Rüttenscheid, June 29, 2011

Training on Fraueninsel
Lecture: Acute Coronary Syndrome - care in general practice – advantages of a fixed combination!
Kloster Fraueninsel am Chiemsee, May 21, 2011

DGIM Symposium of the German Society for General and Family Medicine Barfuß-Physicians versus Fly-Leg Counters
Lecture: Stable CHD – does coronary intervention benefit – and whom? Controversy over the new ESC Guidelines
Wiesbaden, May 2, 2011

XXI Workshop of Interventional Cardiology:
Lecture: The Resolute Clinical Programme: Current Status
Hradec Králové, Czech Republic, April 8, 2011

Kuntz RE, Speiser B, Joyal M, Bonan R, Arseneault A, Neiss G, Cox D, Kirsch M, Laskey W, Suntharalingham M, Wilmer C, Brown C, Schwaibold F, Silber S, von Rottkay P, Fischman D, & Savage M, Pocock S, Abdalla for the Beta-Cath System Trial Investigators
Clinical and Angiographic Outcomes After Use of Sr-90 Beta Radiation for the Treatment of De Novo and Restenotic Coronary Lesions – the BETACATH Trial
ACC (Annual Meeting of the American College of Cardiology) in Orlando, Florida March 2011
ppt presentation

Acute Coronary Syndrome - what to do?
Current guideline-based treatment recommendations for general practitioners and cardiologists Lecture: after hospitalization: which long-term therapy is used in practice?
Berlin, March 30, 2011

Heart Days Training Course Catheter Lab Part 3: PCI Instruments
Moderation Lecture:Drug-eluting Stents and Drug-Eluting Balloons Part 4: PCI – Complex Interventions Lecture: Vein graft including protection systems Part 6: Workshops in rotational format Lecture:Coronary interventions: what is evidence-based?
Essen, March 25, 2011

RSICA Congress:
Plenary Session: “New generation of DES, DEB and Bioabsorbable stents”. Lecture: As an Interventional Cardiologist, which DES would you like to have in your arteries? Plenary Session: Modern Interventional Cardiology and Angiology Lecture:Evolution in management of in-stent-restenosis. DEB.
Moscow, March 21, 2011

Heart Failure in Focus – Diagnostics and Therapy 2011:
Lecture:DMP Module Heart Failure: what is new – what is missing?
Erlangen, March 16, 2011

Heart Failure in Focus – Diagnosis and Therapy 2011
Welcome and Introduction
Munich, March 9, 2011

DINK:
Treatment of acute coronary syndrome in 2011 Lecture:ESC Guidelines on myocardial perfusion – what is new?
Wiesbaden, February 25, 2011

Continuing education event Current Topics in Cardiology – New networking concept of the Passau District Hospital gGmbH
Lecture: A bridge from hypertension to acute coronary syndrome with current pharmacotherapy (DMP recognition)
Pocking, February 24, 2011

Cardiology Update 2011 Revascularisation, ACS, Antithrombotics Satellite Symposium
Lecture: Convincing New Stent Developments
Davos, Switzerland, February 17, 2011

Symposium: JIM – Joint Interventional Meeting Live Case Commentator
Live Cases from Milan, Italy Live Cases from Essen, Germany
Rome, Italy, February 10–11, 2011

15th Symposium for Interventional Cardiology and Angiology LiveCourse 2011
Lecture:Anatomical or functional diagnostics in suspected CHD
Hamburg, February 5, 2011

Acute Coronary Syndrome – what to do?
Lecture:pre-hospital: What immediate measures should the first responder (GP, emergency service etc.) take?
Düsseldorf, February 2, 2011

Quality Circle “Focus Diabetes”
Lecture: Arterial Hypertension – the painless risk
Burghausen, January 27, 2011

11th Cardiology Symposium 2011 Status Quo – Current Trends in Cardiology II. Session: Cardiology – Cardiac Surgery Live transmission from the catheter labs of Sana Clinic Lichtenberg and the hybrid OR of DHZB
Panel III. Session: New Data and Guidelines Under Review Lecture: Why did the Heart Team have to be established?
Berlin, January 22, 2011

ICI Congress
Drug-Eluting Balloons Chair Drug-Eluting Balloons (cont.) Lecture:DIOR in Coronary Intervention Lunch Symposium: MGuard, New Evidence in Acute MI Panel Regulation in the Changing Economic and Ethical Environment Lecture:DES: New Recommendations of the ESC
Tel Aviv, Israel, December 7, 2010

p-c-i live Congress
Munich, December 2–3, 2010

Acute Coronary Syndrome – what to do?
Lecture:pre-hospital: What immediate measures should the first responder (GP, emergency service etc.) take?
Erlangen, November 24, 2010

DGK Autumn Meeting Session of the Conference President:
Imaging in acute chest pain Lecture:Nuclear Medicine Symposium: Dual antiplatelet therapy in patients with ACS and PCI Chair
Nuremberg, October 7, 2010

Acute Coronary Syndrome – what to do?
Lecture:pre-hospital: What immediate measures should the first responder (GP, emergency service etc.) take?
Munich, October 6, 2010

ESC Highlights 2010
Welcome and Moderation Lecture:Latest Guidelines on CHD! ‘What should the GP do – what should be left to the clinic?’
Munich, September 29, 2010

11th International Symposium Düsseldorf Current Developments in Cardiology
Lecture: Latest Guidelines
Düsseldorf, September 17, 2010

Heart Days
Part 1: Current Guidelines (compressed) Moderation Lecture:Current indications for elective cardiac catheterization (ESC 2010) Part 3: PCI Instruments Lecture: Drug-eluting Stents and Drug-eluting Balloons Part 4: PCI – Complex Interventions Lecture: Vein graft including protection systems
Duisburg, September 10, 2010

Lecture:
“Optimal therapy of acute coronary syndrome: between Scylla and Charybdis – How do physicians and patients survive this odyssey?”
Landau, June 23, 2010

Cardiac Catheter Symposium
Lecture: “Confusion in therapy with Clopidogrel and Prasugrel in ACS”
Mühldorf, June 12, 2010

11th Heart Action Weimar
Chair:The cardiac patient with…
Weimar, May 29, 2010

EuroPCR Symposium What do Resolute All Comers Data tell us about the treatment of complex patients and complex lesions?
Chair, Lecture: Challenges in treating complex lesions: What answers does the Resolute All Comers trial provide?
Paris, France, May 27, 2010

EuroPCR Evening Symposium
MGuard – two Years Experience in Acute MI Panel
Paris, France, May 26, 2010

59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery – Heart and Health Foundation of Turkey (HHFT) Lunch Symposium IAIC Session Drug-Eluting Stents: A new paradigm in interventional cardiology Lectures:

• Transferability of data between different drug-eluting stents
• STEMI: Early intervention – Thrombus aspiration

Izmir, Turkey, April 17, 2010

DGIM Pro-Con Session Controversial topics in cardiology (case-based)
Lecture:The Drug-Eluting Stent should be used primarily in coronary revascularization: PRO
Wiesbaden, April 11, 2010

DGK 76th Annual Meeting
Poster Lectures: Risk factors/elderly patients Poster Lecture: Cardiovascular risk profile within an integrated CHD care project – comparison between healthy and diseased Poster Lecture: 10-year risk of myocardial infarction in healthy men – comparison of risk distribution for a current care research project with the prospective cardiovascular Münster Study Poster Lecture: Primary prevention of CHD within a care project – improvement of the 10-year risk for myocardial infarction within the first year of participation Symposium: Paradigm shift in dual antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention Lecture: TRITON-TIMI 38: Which patients benefit particularly, which do not? Free Lectures: Diagnosis and Risk Stratification of Patients with Chest Pain Lecture: The importance of chest pain history for efficient cardiovascular risk stratification of healthy subjects Symposium Innovative Concepts for Coronary Intervention Lecture: “EPC capture stenting” in clinical practice – Results of the e-HEALING Registry in 5,000 patients Hotline III Lecture: Cardiovascular risk profiles in an integrated care project for prevention and therapy of CHD
Mannheim, April 8–10, 2010

ACC Coronary Artery Disease
Panel Discussion
Atlanta, USA, March 14, 2010

Modern Diagnostics and Therapy of Acute Coronary Syndrome (ACS)
Lecture: How much diagnostics are necessary in ACS? What is indispensable, what is useful, and what is superfluous? Always cardiac catheter? Stent vs. Bypass
Neuoetting, March 4, 2010

14th Workshop with Live Demonstrations Medication Accompaniment Therapy in Cardiac Interventions
Session I: Coronary Stent Implantation Lecture:DES follow-up: How long dual antiplatelet therapy? 6 months, 12 monthsor lifelong?
Berlin, February 27, 2010

10th Cardiology Symposium 2010 Status Quo – Current Trends in Cardiology II. Symposium: Target and Actual Determination in Rhythmological and Cardiovascular Therapy of Patients with Heart Failure
Lecture:Guidelines for coronary heart disease – what must one do, what can one do? II. Session Panel: Cardiology – Cardiac Surgery Live
Berlin, January 15–16, 2010

Preparatory course for cardiology exam
Lecture: Coronary heart disease II. Guidelines: Prognostic evaluation, scoring systems. Imaging: Nuclear medicine methods (ischemia, viability). Pharmacological therapy and secondary prophylaxis.
Dachau, December 4, 2009

p-c-i live Congress
Opening and objectives Lunch symposium 2 Lecture: Drug-eluting stents: State of the art 2009 Closing of Congress
Munich, November 26–27, 2009

Schwabinger Heart & Vascular Forum
Lecture: Stent or bypass surgery after COURAGE and SYNTAX
Munich, November 21, 2009

Modern diagnostics and therapy of acute coronary syndrome (ACS) Lecture
Altötting, November 10, 2009

48th Bavarian Internists’ Congress Cooperation of outpatient specialists with hospitals
Lecture: From the perspective of the outpatient specialist
Munich, November 7, 2009

Great Minds
Lecture: DES state of the art: How valid are the data from randomized trials and how applicable are they for new DES platforms?
Istanbul, Turkey, October 30, 2009

EL CONGRESO DE LAS ENFERMEDADES CARDIOVASCULARES FOCUS EN EL DIAGNÓSTICO Y TRATAMIENTO DE LAS ENFERMEDADES CORONARIAS / FOCUS ON THE DIAGNOSIS AND TREATMENT OF CORONARY HEART DISEASES
Lecture: Has the approach to coronary revascularization changed after recent clinical trials?
Barcelona, Spain, October 22, 2009

The diabetic cardiac patient Continuing education in cooperation with Foundation “The heart-sick diabetic” Professional association of interventional cardiologists e.V.
Lecture: Stent choice in diabetics: Conventional bare-metal stents or drug-eluting stents?
Berlin, October 21, 2009

DGK Session of the Conference President Unresolved problems of combining anticoagulation and antiplatelet therapy
Lecture: Cave stent thrombosis: The interventionalist’s perspective
Dresden, October 9, 2009

The diabetic cardiac patient Continuing education in cooperation with: Foundation “The heart-sick diabetic” Professional association of interventional cardiologists e.V.
Lecture: PCI in diabetics: What special considerations?
Munich, September 30, 2009

ESC Clinical Seminar What every cardiologist should know about drug-eluting stents
Lecture: Current indications for drug-eluting stents.
Barcelona, Spain, September 1, 2009

ESC Clinical Seminar, Webcast Take-home messages for practitioners In collaboration with the Council for Cardiology Practice
Lecture: Risk stratification and coronary heart disease.
Barcelona, Spain, September 1, 2009

ESC Focus Session
Percutaneous coronary intervention: Antithrombotic therapy Chairperson
Barcelona, Spain, August 30, 2009

Symposium Dyspnea: From symptom to diagnosis – The patient in our daily practice (case discussions)
Chair Lecture: Advances in therapy of CHD: A blessing for humanity or a health policy disaster?
Munich, July 25, 2009

Atrial fibrillation: The future begins 2009!
Welcome and introduction
Munich, July 15, 2009

Medical education “Modern (post) treatment of acute coronary syndrome: What should the general practitioner consider?”
Lecture: “Can the (post) treatment of acute coronary syndrome from a cardiological perspective be further improved?”
Munich, June 24, 2009

CARDIOLOGISK VA Joint symposium ESC Council of Cardiology Practice/Private Practicing Cardiologists’ Forum/Norwegian Society of Cardiology
Lecture: When to re(re-)revascularize or have the COURAGE to defer another angio? Are the ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for revascularization applicable to European practice for chronic stable angina?
Tromsø, Norway, June 18, 2009

EuroPCR ACC-i2 Summit @ EuroPCR – Unresolved/poorly addressed issues: ACC and EuroPCR/EAPCI initiatives Under the auspices of the American College
Co-chairperson Lecture: Introduction and objectives Roundtable discussion
Barcelona, Spain, May 21, 2009

Literaturhaus Munich Heart & Diabetes, Cardiology Today
Lecture: Interventional and surgical therapy of CHD case discussions on the same topic
Munich, May 16, 2009

Allgäu Heart and Vascular Days Coronary heart disease
Chair Lecture: Conservative versus interventional therapy of coronary stenosis Commentary: Live case transmission from the Heart and Vascular Center Oberallgäu: PTCA and DE-stenting
Oberallgäu, Ofterschwang, May 14, 2009

German Museum Heart & Diabetes, Cardiology Today
Chair, welcome, introduction Lecture: Interventional and surgical therapy of CHD Summary
Munich, May 9, 2009

ACC Vascular Access and Closure
Panel Lecture: New generation closure devices: An update
Orlando, USA, March 29, 2009

hdz Medical Meeting
Scientific direction Topic: CHD – how would you have decided? Lecture: The modern definition of CHD Lecture: Stent or bypass surgery? Are the newest guidelines already outdated?
Munich, March 21, 2009

Symposium “Acute coronary syndrome – intervention and pharmacotherapy”
Session I: Clinical intervention Lecture: Drug-eluting stents – Quo vadis?
Berlin, March 20, 2009

Update on Cardiovascular Therapy Workshop III: Cardiological care of chronic coronary patients
Lecture: MRI and CT – new gold standards in coronary diagnostics? Pro and contra
Munich, February 28, 2009

JIM
Case study 1: Pharmacology and stent decision in STEMI intervention Lecture: Case 1: A high-risk STEMI patient Lecture: Case conclusion and discussion Lunch Symposium Hot Topics 2 Lecture: Transferability of data between different drug-eluting stents
Rome, Italy, February 12–13, 2009

Anaesthesia Today ASS discontinued!! – Postpone surgery!! Problem of perioperative stent thrombosis
Lecture: How long mandatory dual antiplatelet therapy after coronary stent implantation? What do the guidelines say? When can one deviate from the guidelines?
Gräfelfing, February 4, 2009

DMP and KVB Diagnosis and therapy “Coronary artery diseases”
Welcome and introduction Lecture: Invasive diagnostics and stenting: What is necessary – what is optimal? Who should be dilated, who should be operated on?
Munich, January 31, 2009

The 5th International Cardiac Congress of Saud Al-Babtain Cardiac Center Coronary artery disease in diabetic patients
Chair Coronary artery disease in diabetic patients Chair Live case Lecture: How to choose DES in DM?
Dammam, Saudi Arabia, January 13, 2009

The 5th International Cardiac Congress of Saud Al-Babtain Cardiac Center and The 20th Scientific Session of the Saudi Heart Association
Chair Al-Khobar
Saudi Arabia, January 12–15, 2009

p-c-i live Congress
Opening and objectives
Theme block 3: Stent or bypass surgery?
Opening lecture of day 2: Requirements for modern bypass surgery
Chair
Lecture: State-of-the-art lecture: Modern diagnostics and therapy of CHD
Farewell
Munich, December 4–5, 2008

Medica Congress
New cardiological guidelines
Lecture: Percutaneous coronary intervention: Indication, stent selection, outpatient follow-up
Düsseldorf, November 21, 2008

ESC – Acute Cardiac Care
Advanced percutaneous coronary interventions
Lecture: Pros and cons of thrombectomy devices in STEMI.
Versailles, France, October 28, 2008

DGK Autumn Meeting
Academy Program
Interventional cardiology
Chair
Hamburg, October 9, 2008

9th International Symposium Düsseldorf
3rd Generation drug-eluting stents and new PTCA techniques
Lecture: New drug and cell coatings, biodegradable polymer
Düsseldorf, September 19, 2008

ESC Pre-Congress Meeting
Current problems in preventive cardiology
Lecture: Is the use of stents appropriate?
Feldafing, August 29, 2008

SOLACI
DES Summit I
Lecture: Update on Taxus trials
Meeting the clinical cardiologist I
Lecture: Calcium scoring makes sense for primary prevention
DES: Update and perspectives (Evening symposium)
Lecture: Evidence-based medicine
Case-based crossfire discussion
Lecture: Diabetic patient with multivessel disease. Take-home message
Cancún, Mexico, August 6–8, 2008

The 17th Annual Meeting of the Japanese Society of Interventional Cardiology (17th JSIC)
President’s invited lecture
Lecture: Can PCI exceed bypass surgery?
–What improvement is needed to exceed bypass surgery– (tentative)
Lecture: TAXUS Express 2 stent post-marketing surveillance results of initial clinical follow-up (tentative)
Japan, July 3–5, 2008

BNK Symposium
Acute coronary syndrome and stable angina pectoris: Claims and reality – discussed with you using 5 case examples
Scientific direction
Lecture: STEMI
Cologne, June 21, 2008

BNK Symposium
Acute coronary syndrome and stable angina pectoris: Claims and reality – discussed with you using 5 case examples
Lecture: Case example 1: STEMI
Stuttgart, June 14, 2008

hdz – CHD
A variable disease entity with different facets
Welcome & presentation of different facets of CHD
Lecture: Typical angina pectoris: Always catheterization? Stents for everyone?
Munich, June 7, 2008

British Cardiovascular Society
Annual Scientific Conference
British Cardiovascular Society (BCS)
European Society of Cardiology (ESC)
British Cardiovascular Intervention Society (BCIS)
Guidelines: Development and delivery
Lecture: PCI guidelines – how we do it
Manchester, UK, June 3, 2008

Acute coronary syndrome and stable angina pectoris:
Claims and reality – discussed with you using 5 case examples
Scientific direction
Welcome and moderation
Lecture: STEMI
Hamburg, May 31, 2008

Update on Cardiovascular Therapy
Lecture: MRI and CT – new gold standards in coronary diagnostics? Pro and contra
Frankfurt am Main, May 24, 2008

EuroPCR
Drug-eluting stents in challenging patients and lesions
Chair: Objective: To review the evidence for using specific drug-eluting stents in challenging patients and lesion types
Take-home message
Symposium: When safety meets efficacy – Nobori drug-eluting stent
Lecture: Nobori 1 results update
TCT @ EuroPCR – Hot topics in interventional cardiology
Under the auspices of the Transcatheter Cardiovascular Therapeutics (TCT)
Chair
Barcelona, Spain, May 13–16, 2008

Hot Topic “Cardiology”
Drug-eluting stents (DES): Why – Why not?
Lecture: Position paper of the DGK on efficacy and safety of DES
Berlin, April 11, 2008

74th Annual Meeting of the German Society of Cardiology – Heart and Circulatory Research
Invited lecture – “Keynote Lecture”:
Drug-eluting stents – quo vadis?
Mannheim, March 28, 2008

Treatment of the patient with myocardial infarction 2008: Optimal reperfusion strategies for STEMI and NSTEMI
Chair
Munich, February 23, 2008

LiveCourse 2008
13th Symposium on Interventional Cardiology and Angiology
Under the patronage of the German Society of Cardiology – Heart and Circulatory Research
Lecture: “Off-label” versus “on-label” use of drug-eluting stents: Increased risk, lower benefit
Hamburg, February 2, 2008

Dresden Cardiovascular Days 2008
Modern concepts in diagnosis and therapy of cardiovascular diseases
VIII. Drug-eluting stents: Does every patient need a DES?
Lecture: Indication for DES – pro
Dresden, January 27, 2008

4th Bochum Symposium on Physiology in the Cardiac Catheterization Lab
Lecture:
Update on drug-eluting stents: Are all the same? What is established?
Bochum, January 25, 2008

ICI
Current problems in drug-eluting stents
Lecture: DES efficacy – safety balance – The right to choose
Tel Aviv, Israel, December 3, 2007

INNOKARDIO + BNK
Acute coronary syndrome and stable angina pectoris: Claims and reality – discussed with you using 5 case examples
Scientific direction
Welcome and moderation
Lecture: Case example 1: STEMI
Munich, December 1, 2007

Focus Session Cardiology
Case presentations: Symptoms, diagnostics, and therapy options
Controversial questions, common and rare diseases
How would you have decided?
Welcome, introduction, session
Munich, October 17, 2007

DMP-CHD Continuing Education of KVB
Diagnosis and therapy of coronary artery diseases
Lecture: CHD: invasive diagnosis and treatment
Würzburg, September 29, 2007

ESC
Abstract Session
Trials and registries in percutaneous coronary intervention
Chair
Symposium
Implementation of ESC practice guidelines for percutaneous coronary interventions in Europe – impact on long-term outcome. Lessons from the Euro Heart Survey Programme
Lecture: Long-term outcome of PCI in multivessel disease.
Abstract session/Poster session 5
Lecture: Value of cardiac CT in addition to myocardial perfusion scintigraphy.
Take-home messages for practitioners
“Clinical Seminar in collaboration with the Council for Cardiology Practice”
Lecture: Risk stratification and coronary artery disease.
Vienna, Austria, September 2–4, 2007

ESC
Abstract:
Final 5-year clinical follow-up of TAXUS II: Long-term anti-restenotic efficacy and safety for both slow- and moderate-release polymer-based paclitaxel-eluting TAXUS stents
Vienna, September 2007

ESC
Abstract
Value of cardiac CT in addition to myocardial perfusion scintigraphy
Vienna, Austria, September 2007

ESC
Abstract
Gender differences in the application and outcome of PCI, Euro Heart Survey PCI
Vienna, Austria, September 2007

hdz Continuing Education Event: New in diagnostics and therapy of CHD
Lecture: Non-obstructive CHD: Why is it important to diagnose?
Munich, July 28, 2007

DMP-CHD Continuing Education of KVB
Diagnosis and therapy of “Coronary artery diseases”
Lecture: CHD: invasive diagnosis and treatment; diagnostics also with respect to DMP enrollment; indication for surgery; pros and cons of uncoated and coated stents;
Munich, June 30, 2007

Bogenhausen Cardiology Seminar
Lecture: Guideline-based indications for cardiac CT and cardiac MRI
Munich, June 20, 2007

Great Minds in Berlin
German-Austrian expert meeting on focused topics in interventional cardiology
Lecture: What do the guidelines say? On what evidence are they based?
Lecture: Difference or equivalence – all a matter of study design?
Moderation: “Long-term outcomes after drug-eluting stents”
Berlin, June 15–16, 2007

Austrian Society of Cardiology
Annual Meeting 2007
“Pro-healing stent: New stent developments: GENOUS – EPC capturing technology” WERFEN Austria/ORBUS NEICH
Lecture: How safe are “drug-eluting stents”?
Salzburg, Austria, May 31, 2007

talking eyes & more
International symposium
Cardiovascular prevention – “State of the art”
Lecture: “Evidence-based identification of high-risk patients in primary prevention of coronary artery disease”
Nürnberg, May 26, 2007

EuroPCR
Late-breaking coronary trials
Panel
Take-home message
Coronary drug-eluting stents: Current questions, future perspectives
Lecture: Debate on duration of dual antiplatelet therapy: 6-month antiplatelet post-coronary drug-eluting stent
Optimizing coronary drug-eluting stent results in diabetics
Chair
Lecture: Introduction and learning objectives
Take-home message
Percutaneous coronary intervention in acute and later phases of myocardial infarction
Lecture: Do we need to update the guidelines?
May 22–24, 2007

Medical Continuing Education Event
Lecture: “New guideline on the use of drug-eluting coronary stents – What are the implications for general practitioners’ drug budgets?”
Munich, April 26, 2007

73rd Annual Meeting of the German Society of Cardiology – Heart and Circulatory Research e.V.
Cardiovascular imaging
Associated member
Commission for Clinical Cardiology
Project group “Quality assurance and registry”
Project group “Integrated care”
Cluster I: Intervention
Poster presentations: Innovative therapy options in AMI
Discussion leader
Poster presentations: Stents
Late complications after Taxus stent implantation in a consecutive patient population of a cardiology practice
Main session: Importance of coronary calcium detection
Lecture: Indications for calcium detection, patient self-assignment, consequences and cost-benefit aspects etc. – Experience from outpatient care
Symposium: Second-generation drug-eluting stents: Clinical experiences and outlook
Lecture: Safety and efficacy of current DES systems in comparison
Poster presentations: Hypertension: clinical and experimental
Lecture: Undertreatment of patients with arterial hypertension in Germany: Results of the BNK Snapshot registry in 7,302 patients
Hotline
Lecture: Kardio-Pro: an innovative care concept for care research of patients with stenotic and non-stenotic coronary heart disease
Poster presentations: Risk indicators and treatment reality
Lecture: Different coronary calcium scores in patients with and without subsequently observed cardiovascular events: Results in over 3,213 patients
Working group “Interventional Cardiology”
Coronary and non-coronary interventions in the catheter lab
Lecture: What still needs improvement in drug-eluting stents?
Lecture: EuroSTAR II: First randomized, controlled study of the paclitaxel-eluting COSTAR stent compared to the uncoated cobalt-chromium stent
Symposium PRO-HEALING stent: the new standard for coronary stents?
Chair, summary
Main session, Guideline session 3
Lecture: Position of the DGK: How safe are drug-eluting stents? The role of clopidogrel
Working group “Cardio-CT”
Role of cardiac CT in routine cardiological diagnostics
Lecture: How can one bill for cardiac CT examinations?
Poster presentation: CHD: Risk factors
Lecture: Different age dependency of elevated calcium scores in patients with and without subsequent coronary event: Results in over 3,213 patients
Free lectures: Restenosis and stent
Lecture: Accelerated healing of coronary stents via active enrichment of circulating endothelial progenitor cells: First results of the e-HEALING registry study in over 2,000 patients
Mannheim, April 12–14, 2007

ACC Roundtable
Topical issues with drug-eluting stents
Co-chair
New Orleans, USA, March 26, 2007

ACC
Drug-Eluting Stent Revolution IV
Lecture: DES safety vs. efficacy: Diverse viewpoints on the appropriate utilization of DES, BMS, and CABG
Lecture: Evidence-based medicine indications for DES usage: European recommendations
Roundtable discussion and audience Q&A: Selection of DES vs. BMS vs. surgery
Lecture: Back to the patient: A case-based forum
Lecture: The Case III: Diffuse multivessel disease (Type II diabetes)
New Orleans, USA, March 23, 2007

Health policy cardiology 2007
Outpatient cardiology
Chair
Appropriateness of cardiological indications
Lecture: Late stent thromboses: How safe are DES now?
Outpatient cardiology
Lecture: The outpatient cardiologist at the center of the IV: Example CardioPlus
Potsdam, January 23–24, 2007

Hot topics in cardiology and cardiac surgery
Lecture: Drug-eluting stents
But more complications?
Mainz, January 17, 2007

Symposium “Current Cardiology”
Lecture and response: Are drug-eluting stents safe and effective? Pro
Berlin, December 13, 2006

ICI
New stent technologies: Raising the bar on clinical outcomes
Panel
Lecture: The role of drug-eluting stents (DES) in acute myocardial infarction with ST-segment elevation (STEMI)
Tel Aviv, Israel, December 4, 2006

BNK Year-End Meeting
Chair
Lecture: Evolution of PCI – pitfalls and highlights
Hamburg, November 25, 2006

Scientific Congress: Hypertension 2006
“The hypertensive patient in cardiological practice”
Chair
Lecture: Results of a snapshot survey by BNK
Munich, November 22, 2006

Medica Congress
Lecture: Computed tomography
Düsseldorf, November 17, 2006

AHA
A new stainless-steel-free stent with potential for artifact-free magnetic resonance compatibility: First clinical experience
Poster
Chicago, USA, November 12, 2006

TCT
Clinical trials
Abstract: First five-year clinical follow-up from a randomized trial of a polymer-based, paclitaxel-eluting stent: TAXUS I
Washington, DC, USA, October 23, 2006

Atrial fibrillation – Update
3M Continuing Education Events under the patronage of BNK
Scientific direction
Munich, October 18, 2006

Chiemgau Cardiology Days
Chair
Lecture: Drug-eluting stents: standard or still in need of improvement?
Gut Ising, September 23, 2006

Treatment strategies after stent implantation
Lecture: Current role of clopidogrel in interventional cardiology
Hotel Schloss Hohenstein, Ahorn, October 14, 2006

ESC
Experts of the Take-Home Session
Lecture: Coronary artery disease
Barcelona, Spain, September 4, 2006

Essen/Mayo meets BNK
Myocardial and valvular heart – Update 2006 for clinic and practice
1st Chairman of BNK
Essen, May 19, 2006

EuroPCR
Opening symposium: The great debate on drug-eluting stents
Panel
Late breaking trials and clinical trial updates
How to critically analyze randomized trials and registries
Synthesis and implications for practice
Lectures
Percutaneous cardiovascular intervention in Europe: Looking towards the future
Panel
Lecture: How to actively involve the national working groups
New diagnostic approaches in patients with suspected coronary artery disease
Panel
The role of a healing stent: Safety is mandatory
Chair
CRT @ EuroPCR
Lecture: How to select commercially available drug-eluting stents: Based on guidelines
EuroPCR, May 16–18, 2006

Healthcare in Transition
Is the course correct?
Symposium of the Federal Association of Outpatient Cardiologists (BNK)
Summary and outlook
Ludwigshafen am Rhein, May 12, 2006

4th Dresden Symposium
"Diabetes mellitus and coronary heart disease – prevention and early diagnosis"
Chair
Lecture: Is calcium scoring meaningful in diabetics?
Dresden, May 6, 2006

General Practitioners' Circle Munich
CHD and stent implantation
Lecture: Which patient needs which stent?
Munich, May 4, 2006

112th Congress of the German Society of Internal Medicine
Claim and reality in cardiology
Lecture: Pro – implantation of drug-eluting coronary stents is medically indicated and financially feasible
Wiesbaden, April 26, 2006

Modern CHD diagnostics: Do we still need nuclear cardiology?
Lecture
Peiting, April 25, 2006

DGK Main Session
Hotline 3 Register
Lecture: The HEALING-II study
Mannheim, April 22, 2006

DGK
Main session
Simulation training in interventional cardiology – Current role and future perspectives
Chair, welcome, closing remarks
Mannheim, April 22, 2006

DGK
Guideline session 2
Chair
Mannheim, April 21, 2006

DGK AGIK
Working Group “Interventional Cardiology”
Drug-eluting Stents:
- Are there differences or specific indications?
- What comes next?
Chair
Lecture: The healing stent
Mannheim, April 20, 2006

ACC Summit 2006
Live Case Transmission Session II
Panel
Percutaneous coronary intervention guidelines
Lecture: European percutaneous coronary intervention guidelines
Atlanta, USA, March 12–14, 2006

BNK Imaging Meetings – vision goes reality
Lecture: Nuclear medicine
Optimized myocardial SPECT diagnostics
Erlangen, March 3–4, 2006

Health Policy Kickoff of Cardiology
Controversial Issues 2006
Political roundtable on health policy in cardiology 2006:
Will we be able to solve revenue-side problems on the expenditure side?
Main session I
Chair
Main session II
Chair
Main session III
Chair
Potsdam, March 2, 2006

6th International Symposium on Cardiovascular Interventions
3. Coronary Interventions
Lecture: Different DES in complex lesions – are the clinical results still the same?
6. Peripheral artery interventions
Satellite symposium
Lecture: Are all DES the same?
Kitzbühel, Austria, February 20, 2006

Guidelines Hot Topic Seminar
Lecture: European guidelines/international guidelines
Frankfurt am Main, February 14, 2006

S. Silber, B. Richartz, B. Bischoff, L. Pieper, J. Klotsche, H.-U. Wittchen
Increased waist circumference as a cardiovascular risk factor in Germany: Results in over 55,000 patients
Clinical Research in Cardiology, Suppl., (2006)

S. Silber, B. Richartz, B. Bischoff, L. Pieper, J. Klotsche, H.-U. Wittchen
Inadequate pharmacological therapy of CHD in Germany: Results of the DETECT study compared to EUROASPIRE I and II
Clinical Research in Cardiology, Suppl., (2006)

S. Silber, B. Bischoff, B. Richartz, L. Pieper, J. Klotsche, H.-U. Wittchen
Different results for the PROCAM score, Framingham score, and the ESC score regionalized for Germany in identifying high-risk coronary patients: Results in 48,623 individuals
Clinical Research in Cardiology, Suppl., (2006)

S. Silber, G. Stone
Efficacy and safety of the Taxus stent: combined analysis of 3445 patients from 4 randomized trials
Clinical Research in Cardiology, Suppl., (2006)

E. Moroder, P. Lochow, I. Krischke, H. Mühling, A. Schmid, Chr. Willert, B. Richartz, S. Silber
Are the results of randomized trials with paclitaxel-eluting coronary stents transferable to everyday clinical practice?
Clinical Research in Cardiology, Suppl., (2006)

S. Silber, B. Richartz, B. Bischoff, A. Schmermund
The risk thresholds for high coronary risk determined by electron beam computed tomography (EBCT) cannot be directly transferred to modern multislice computed tomography (MSCT)
Clinical Research in Cardiology, Suppl., (2006)

Spanish Society of Cardiology
Invited lecture:
Outpatient management of heart failure
Barcelona, Spain, October 26, 2005

TCT
Session III: Updates on current device options: device description, data, and optimal technique
Moderator
Lecture: Duett balloon occlusion with an external biological procoagulant
Controversies in ACS, AMI, and PCI treatment pathways: Reconciling the guidelines
Co-Moderator
Section I: Optimal treatment for the patient with STEMI presenting at a noninterventional facility: Drip and/or Ship?
Lecture: Review of the data
Panel discussion and audience Q&A
Discussant
Section IV: Thrombectomy and distal protection devices in ACS and AMI
Panel discussion and audience Q&A
Discussant
Live-case session
Live case discussant
Session II: Studies with new bare metal stents
Lecture: Featured lecture. Results with two niobium/iridium oxide stents
Session III: TCT Abstracts
Discussant
Washington, USA, October 16–21, 2005

ESC
New practice guidelines of the European Society of Cardiology
Lecture: Percutaneous coronary intervention
Stockholm, September 4, 2005

S. Silber
Are coronary interventions necessarily inpatient?
Z Kardiol 94: Suppl. 2 (2005) Commentary

S. Silber, S. Finsterer, M. Vogel, M. Rothmeier
Improved identification of high-risk coronary patients by combined use of myocardial scintigraphy and calcium plaque scoring: Results in 900 consecutive individuals
Z Kardiol 94: Suppl. 2 (2005)

S. Silber, B. Bischoff, A. Schmermund
Does the new multislice computed tomography underestimate coronary calcium scoring compared to the older 4-slice multidetector computed tomography? Results from 8000 patients
Z Kardiol 94: Suppl. 2 (2005)

S. Silber, A. Colombo, K.E. Hauptmann, J. Drzewiecki, E. Grube
Clinical results of the TAXUS II study at 3 years: durability of polymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.
Z Kardiol 94: Suppl. 2 (2005)

S. Silber, E. Grube, K. Hauptmann on behalf of the TAXUS-I study participants
3-year results of paclitaxel-eluting coronary stents.
Z Kardiol 94: Suppl. 1 (2005) P 735

S. Silber, I. Krischke, P. Lochow, Chr. Drexler, S. Stärk, B. Bosnjak, A. Witzgall
Avoidance of bypass surgery due to in-stent restenosis by intracoronary brachytherapy: Results of a 3-year follow-up.
Z Kardiol 94: Suppl. 1 (2005) V 287

S. Silber, S. Böhler, D. Pittrow, H. Glaesmer, J. Klotsche, W. Böcking, W. Kirch, H. Scharnagl, W. März, G. Ruf, H.-U. Wittchen, G. Stalla, H. Lehnert, on behalf of the DETECT study group
Deficits in diagnosis and treatment of patients with diabetes mellitus in general practice: Results of the DETECT study.
Z Kardiol 94: Suppl. 1 (2005) P 988

S. Silber, S. Böhler, H. Glaesmer, J. Klotsche, F. Freisinger, D. Pittrow, W. Böcking, W. Kirch, G. Ruf, G. Stalla, H. Lehnert, W. März, H.-U. Wittchen
Undertreatment in antihypertensive and lipid-lowering therapy in general practitioners' offices: Results of the DETECT study
Z Kardiol 94: Suppl. 1 (2005) P 427

S. Silber, A. Colombo, A. Banning, K. Hauptmann, E. Grube
Investigation of late stent thromboses 18 months after discontinuation of dual antiplatelet therapy with paclitaxel-eluting coronary stents.
Z Kardiol 94: Suppl. 1 (2005) P 125

S. Silber, J. Hamburger, E. Grube, M. Pfisterer, J. Belardi, A. Colombo
Direct Stenting With TAXUS Stents Is as Safe and Effective as After Predilatation.
Z Kardiol : Suppl. 1, (2004) P 720

S. Silber, E. Grube, J. Belardi, A. Colombo
Paclitaxel-Eluting Stents in Complex Lesions
Z Kardiol 93: Suppl. 5, (2004) P 299

S. Silber, J. Shemesh, N. Weg, H.-C. Yoon
International Multicenter Study to Determine Coronary Calcification Distribution Measured by Multislice CT in 5,345 Individuals.
Z Kardiol : Suppl. 1, (2004) V 1287

S. Silber, G. Bauriedel, B. Lauer, P. Siostrzonek, T. Münzel
A Stainless-Steel-Free Stent Made of Niobium With Iridium Oxide (IrOx) Coating: First Results of the LUSTY Study
Z Kardiol 93: Suppl. 5, (2004) P 300

S. Silber, Chr. Drexler, I. Krischke, P. Lochow, A. Witzgall
High-Dose vs. Low-Dose Beta Irradiation for In-Stent Restenosis
Z Kardiol : Suppl. 1, (2004) P 771

D. Baumgart, R. Bonan, Chr. Naber, P. Serruys, A. Colombo, S. Silber, E. Eeckhout, P. Urban
Successful Reduction of In-Stent Restenosis in Long Lesions With Intracoronary Beta Irradiation – Subanalysis of the RENO Registry.
Z Kardiol 92: Suppl. 1, I/172, (2003)

T. Schiele, E. Regar, S. Silber, E. Eeckhout, W. Wijns, A. Colombo, W. Rutsch, D. Meerkin, A. Gershlick, R. Bonan, P. Urban
Clinical and Angiographic Acute and Long-Term Outcomes of Intracoronary Beta Irradiation of Bypass Grafts – A Subgroup Analysis of the Multicenter RENO Registry.
Z Kardiol 92: Suppl. 1, I/199, (2003)

S. Silber, A. Schmermund
Detection and Distribution of Coronary Calcification in 4000 Individuals Without Known Coronary Heart Disease (CHD): Results for Multislice CT (MSCT).
Z Kardiol 92: Suppl. 1, I/289, (2003)

A. Schmermund, S. Silber
Discordance Between Risk Factors and Extent of Coronary Atherosclerosis: Analysis Using 4-Slice Spiral CT in 3459 Individuals Without CHD.
Z Kardiol 92: Suppl. 1, I/289, (2003)

P. Lochow, I. Krischke, C. Meier, H. Mühling, S. Silber
Cardiac Catheterization in Asymptomatic Patients With Coronary Calcification on Multislice CT (MSCT) Is Not Indicated.
Z Kardiol 92: Suppl. 1, I/385, (2003)

S. Silber, P. Lochow
Femoral Closure Systems: A Help After Invasive Diagnostics?
Z Kardiol 92: Suppl. 2, II/31, (2003)

P. Lochow, I. Krischke, H. Mühling, S. Silber
Do the Control Groups of the ISAR-Stereo-II, RAVEL and SIRIUS Studies Reflect Outcomes for the BX-Velocity Stent in a Cardiology Practice Under Routine Conditions? Results of 438 BX-Velocity Stent Implantations.
Z Kardiol 92: Suppl. 2, II/100, (2003)

R. Müller, U. Gerckens, K. E. Hauptmann, S. Silber, E. Grube
The TAXUS I Study With the Paclitaxel-Coated NIRx™ Stent – Angiographic Results and Clinical Follow-Up
Z Kardiol 91: Suppl. 1, I/65, (2002)

E. Grube, K. Hauptmann, S. Silber, R. Bach, N. Reifart, A. Colombo, J. Fajadet
Increased Incidence of Stent Thrombosis After Use of a Drug-Eluting Coronary Stent: Results of the SCORE Study.
Z Kardiol 91: Suppl. 1, I/65, (2002)

Sigmund Silber, Eric Eeckhout, Antonio Colombo, H. Heuer, J. Schofer, Raoul Bonan
Treatment of In-Stent Restenosis by Combined Use of Cutting-Balloon PTCA and Brachytherapy: Results of the European RENO Registry
Z Kardiol 91: Suppl. 1, I/273, (2002)

T. M. Schiele, P. W. Serruys, E. Eeckhout, S. Silber, C. Naber, W. Wijns, A. Colombo, W. Rutsch, D. Meerkin, V. Klauss
^90Sr/^90Y Brachytherapy for Treatment of Coronary Vein Bypasses – A Subgroup Analysis of the RENO Registry (European Surveillance Registry With the Novoste™ Beta-Cath™ System)
Z Kardiol 91: Suppl. 1, I/272, (2002)

Silber S., Baumgart D, Colombo A, Serruys P, Meerkin D, Schiele Th, R. Dörr, Kleinertz K, Auch-Schwelck W, Wijns W, Eeckhout E, Urban P
Better Clinical Outcome With Longer Radiation Sources: Final Results of the RENO Registry in 1098 Patients
Z Kardiol 91: Suppl. 1, I/272, (2002)

Sigmund Silber, Thomas Schiele, Antonio Colombo, Patrick W. Serruys, Eric Eeckhout, Raoul Bonan, Philip Urban
Pullback Technique With Sr/Y90 Sources for Intracoronary Brachytherapy of Long Coronary Stenoses: A Subanalysis of the RENO Registry
Z Kardiol 91: Suppl. 1, I/273, (2002)

Sigmund Silber, Peter Lochow, Josef Finsterer for the MUNICH Registry
Comparison Between Prospective and Retrospective ECG Triggering for Exclusion of Coronary Calcification
Z Kardiol 91: Suppl. 1, I/155, (2002)

R. Hoffmann, Med. Clinic I, University of Aachen, G. Herrmann, Med. Clinic, University of Kiel, S. Silber, Cardiac Catheterization Laboratory at Klinik Dr. Müller, Munich, P. Braus, G. Werner, Heart Center Duisburg
Optimal Stent Therapy for Long Coronary Lesions. Randomized Multicenter Comparison of Therapy With One Long Versus Two Short Stents.
Z Kardiol 91: Suppl. 1, I/71, (2002)

DGK
Working Group “Cardio-CT” Lecture: For Whom? (Who Benefits and Who Does Not From Coronary Calcium Detection?)
October 18, 2002

Munich Symposium on Interventional Cardiology
Lecture: Contemporary Use of Arterial Closure Devices Brachytherapy Chair
Munich, October 11/12, 2002

14th Seminar on Applied PTCA
Chair and Lecture: Taxus Studies With Paclitaxel-Coated Stents
Fulda, September 20, 2002

Quality Assurance in the Cardiac Catheterization Laboratory Lecture: Quality Assurance in the Cardiac Catheterization Laboratory From the Perspective of the Office-Based Cardiologist
Berlin, September 9, 2002

ESC
Council of Cardiology Practice: Present and Future of Cardiology by Practicing Cardiologists Lecture: What Can Be Done as a Practicing Cardiologist? Coronary Angiography and Interventions.
Berlin, September 3, 2002

ESC
Recent Clinical Trial Update I: Coronary Disease and Arrhythmias Lecture: START: Two-Year Follow-Up
Berlin, September 2, 2002

ESC
Cardiac Computed Tomography: Something New on the Horizon? Lecture: The MUNICH Registry: “Normal” Distribution of Coronary Artery Calcium Measured by 4-Slice Computed Tomography in Over 2000 Asymptomatic Individuals.
Berlin, September 1, 2002

Expert Meeting on Interventional Cardiology
Lecture: Intravascular Radiation Therapy: Has It Become Superfluous?
Berlin, June 15, 2002

S. Silber:
Coronary intervention: what's new?
Z Kardiol 88: II/48, (1999)

S. Silber, P. v. Rottkay, A. Schneider, A. Gielow, A. Bauer, H. Schöfer:
Dosimetry and radiation exposure of personnel and patients during intracoronary brachytherapy with strontium/yttrium-90.
Z Kardiol 88: II/109, (1999)

S. Silber, P. v. Rottkay, A. Schneider, A. Gielow, H. Schöfer:
Intracoronary afterloading: how to obtain approval?
Z Kardiol 88: II/108, (1999)

S. Silber, N. Seidel, I. Krischke, B. Gessler, K. Naser:
Rotablation is not the solution for diffuse in-stent restenoses.
Z Kardiol 88: II/105, (1999)

S. Silber, K. Naser, N. Seidel, R. von Oepen:
Gold stents do not reduce in-stent restenosis.
Z Kardiol 88: II/107, (1999)

S. Silber, A. Albrecht, S. Goehring, M. Kaltenbach, D. Kneissl, N. Kokott, B. Levenson, D. Mathey, E. Pöhler, N. Reifart, G. Sauer, J. Schofer, F. Schwarzbach:
Complications after PTCA: are there differences between practices and hospitals?
Z Kardiol 88: II/18, (1999)

N. Seidel, I. Krischke, S. Tourlakidou, S. Silber:
Experiences with the Duett™ closure system.
Z Kardiol 88: II/20, (1999)

K. Giokoglu, K.-E. Hauptmann, D. Mathey, J. Schofer, S. Silber, D. Enayat, S. Göhring, N. Reifart:
A new dilation catheter with 3 balloons (Trinity™) for rapid and optimized coronary angioplasty and stent implantation.
Z Kardiol 88: 24, (1999)

S. Silber, N. Seidel, H. Mühling, A. Bauer, P. von Rottkay:
Safety and practicality of intracoronary irradiation using a β-emitting activity source.
Z Kardiol 88: 23, (1999)

S. Silber, A. Bauer, P. von Rottkay:
Intracoronary brachytherapy with strontium/yttrium-90: first experiences in Germany.
Z Kardiol 87: Suppl. 5, 102, (1998)

S. Silber, N. Seidel, H. Mühling, M. Zeitler:
Rotablation of in-stent restenoses in various stent models.
Z Kardiol 87: 257, (1998)

S. Silber, G. Gershony, M. Heberlein, B. Schön, N. Schön:
A new closure concept for arterial puncture sites: first results in patients.
Z Kardiol 87: 81, (1998)

S. Silber, Ch. Luckas, A. Björvik:
Peripheral complication rates of collagen systems after PTCA: a meta-analysis of 6007 published patients.
Z Kardiol 87: 82, (1998)

Silber S, Göhring S, Kaltenbach M, Reifart N, Pöhler E:
Quality assurance in the catheter lab: paperless documentation of diagnostic and therapeutic left heart catheter procedures in 2-3 minutes.
Z Kardiol 86: 153, (1997)

Silber S, Mühling H, Dörr R, Zindler G, Preuss A, Stümpfl A:
Halving the waiting times for coronary bypass surgery does not reduce preoperative risk.
Z Kardiol 86: 216, (1997)

Silber S, Mühling H, Dörr R, Zindler G, Seidel N:
Immediate sheath removal after PTCA: comparison of success and complication rates of three different hemostasis systems in over 1000 patients.
Z Kardiol 86: 129, (1997)

Silber S, Mühling H, Zindler G, Dörr R:
Assessment of quality loss in digitization of coronary angiograms: interobserver variability.
Z Kardiol 86: 203, (1997)

Silber S, Dörr R, Zindler G, Mühling H, Diebel T:
Clinical relevance of different compression rates for the assessment of digital coronary angiograms.
Z Kardiol 85 (2): 78, 1996

Silber S, Mühling H, Dörr R, Zindler G, König U:
Inverse relationship between LIMA bypass frequency and completeness of revascularization.
Z Kardiol 85 (2): 91, 1996

Dörr R, König U, Mühling H, Silber S:
Shortening the application time of the intra-arterial anchor for hemostasis after PTCA is not associated with increased bleeding risk.
Z Kardiol 85: 286, 1996

Silber S, Mühling H, Dörr R, Preuss A, Stümpfl A:
Waiting times for coronary bypass surgery in the Munich area depending on urgency and health insurance: a prospective, randomized study.
Z Kardiol 84: (Suppl. 3), 43, (1995)

Silber S, Björvik A, Rösch A, Mühling H:
Advantages of the collagen plug after PTCA: a prospective, randomized study.
Z Kardiol, 84: (Suppl. 3), 18, (1995)

Dörr R, Zindler G, König UB, Mühling H, Silber S:
Significant cost reduction without increased bleeding risk: AngioSeal enables outpatient Judkins left heart catheter diagnostics with continued Marcumar therapy.
Z Kardiol 84: (Suppl. 3), 18, (1995)

Silber S, Mühling H, Dörr R, Rösch A:
Safety of the collagen plug for hemostasis after femoral puncture in diagnostic and interventional catheter procedures in over 3000 patients.
Z Kardiol 84: (Suppl. 3), 17, (1995)

Silber S, Mühling H, Dörr R, Zeitler M, Diebel T:
The filmless, digital catheter lab with CD-R: technical fundamentals and first experiences.
Z Kardiol. 84: 236, (1995)

Silber S, Zindler G, Dörr R, Mühling H, Luckas Ch:
Rapid mobilization (20 minutes) after diagnostic cardiac catheterization: advantages of the intra-arterial anchor.
Z Kardiol, 84: 92, (1995)

Silber S, Haentsch C, Seidel N, Mühling H:
Rapid mobilization (30 minutes) after diagnostic cardiac catheterization: efficiency and tolerability of the collagen plug in 660 patients.
Z Kardiol 82: 33, (1993)

Silber S, Seidel N, Mühling H, Bödigheimer K:
Outpatient cardiac catheterization after femoral puncture and immediate vessel closure using a collagen plug.
Z Kardiol, 81: 163, (1992)

Silber S, Dean L, Baxley W, Bulle T, Saenz C, Henzlova M, Levson L, Pohost G:
ST-Segment Holter Monitoring after PTCA.
Z Kardiol, 80: 20, (1991)

Silber S, Bajaj RK, Pohost G:
Digital recording of magnitude and duration of ischemic episodes is more accurate than analog Holter monitoring.
Z Kardiol, (Suppl. II), 78: 1989

v. Smekal A, Silber S, Pohost GM:
A new stress method during cardiological MRI.
Z Kardiol, 78: (Suppl. I):15, 1989

Vogler A, Spiegelsberger F, Silber S, Theisen K:
Placebo-controlled assessment of magnitude and duration of effect of a 120 mg isosorbide dinitrate (ISDN) sustained-release capsule.
Zeitschrift für Kardiologie, 75, 81, 1986

Silber S, Vogler A, Theisen K:
Problems of pharmacological anti-ischemic therapy in patients with insufficient nitrate effect.
Zeitschrift für Kardiologie, 75, 93, 1986

Silber S, Vogler A, Spiegelsberger F, Theisen K:
Fully automatic detection of short ischemic episodes with long-term ECG.
Zeitschrift für Kardiologie, 75, 86, 1986

Silber S, Vogler A, Spiegelsberger F, Theisen K:
Lack of relationship between nitrate plasma levels and anti-ischemic effect.
Zeitschrift für Kardiologie, 75, 93, 1986

Silber S, Vogler A, Spiegelsberger F, Theisen K:
Reliable detection of ST segment changes in long-term ECG at rest and during stress.
Klinische Wochenschrift, 64, Suppl. V, 117, 1986

Silber S, Vogler A, Spiegelsberger F, Theisen K:
Nitrate tolerance: can recommendations for optimal plasma levels be given?
Klinische Wochenschrift, 64, Suppl. V, 122, 1986

Silber S, Theisen K, Jahrmärker H:
Oral nitrate long-term therapy: avoiding tolerance development with good 12-hour effect.
Zeitschrift für Kardiologie, 74, Suppl. 5, 84, 1985

Silber S, Spiegelsberger F, Theisen K, Jahrmärker H:
Can the ST segment in long-term ECG be reliably evaluated?
Zeitschrift für Kardiologie, 74, Suppl. 5, 62, 1985

Silber S, Krause KH, Theisen K, Jahrmärker H:
Nitrate tolerance: is there a "critical" threshold for plasma levels?
Zeitschrift für Kardiologie, 74, Suppl. 5, 20, 1985

Scheininger M, Theisen F, Silber S, Stern H, Theisen K:
Influence of amiodarone on left ventricular ejection fraction in patients with heart failure.
Zeitschrift für Kardiologie, 74, Suppl. 3, 14, 1985

Meister W, Schühlen H, Scheininger M, Silber S, Theisen K:
Low or medium digoxin dose in heart failure. A double-blind, randomized crossover study.
91st Annual Meeting of the German Society of Internal Medicine, Wiesbaden, 1985

Silber S, Krause KH, Garner Ch, Theisen K:
Dependence of effect loss under chronic isosorbide dinitrate (ISDN) administration on dosing interval.
Zeitschrift für Kardiologie, 73, Suppl. 1, 16, 1984

Silber S, Krause KH, Garner Ch, Theisen K:
Combined use of exercise ECG and exercise radionuclide ventriculography to assess magnitude and duration of effect of a single 80 mg isosorbide dinitrate sustained-release tablet.
Zeitschrift für Kardiologie 72, Suppl. 2, 24, 1983

Silber S, Kotzur J, Weber M, Haufe M, Theisen K:
Fully automatic calculation of left ventricular ejection fraction with radionuclide ventriculography.
Zeitschrift für Kardiologie, 72, Suppl. 1, 94, 1983

Silber S, Kotzur J, Weber M, Haufe M, Theisen K, Jahrmärker H:
Is rapid digital injection dangerous?
Zeitschrift für Kardiologie, 72, Suppl. 2, 69, 1983

Silber S, Klein U, Rudolph W:
Detection of resolved myocardial infarctions based on scintigraphically determined regional ejection fraction.
Zeitschrift für Kardiologie, 71, 178, 1982

Silber S, Schwaiger M, Klein U, Rudolph W:
Effect of nifedipine on global and regional left ventricular function at rest and during stress in patients with coronary heart disease.
Zeitschrift für Kardiologie, 71, 168, 1982

Silber S, Schwaiger M, Fleck E, Klein U, Rudolph W:
201Thallium computed tomography and conventional scintigraphy for assessment of the results of coronary surgical revascularization procedures.
Zeitschrift für Kardiologie, 70, 262, 1981.

Schwaiger M, Silber S, Klein U, Rudolph W:
Reproducibility of scintigraphically determined left ventricular functional parameters at rest and during stress. Zeitschrift für Kardiologie, 70, 262, 1981.

Silber S, Schwaiger M, Klein U, Rudolph W:
Radial segmental left ventricular ejection fraction: a new method for regional quantification of radionuclide ventriculograms.
Zeitschrift für Kardiologie, 69, 711, 1980

Silber S, Schwaiger M, Klein U, Rudolph W:
Comparison between automatic and manual determination of left ventricular wall boundaries for ejection fraction measurement with radionuclide ventriculography.
Zeitschrift für Kardiologie, 68, 711, 1980

Rudolph W, Silber S, Bierner M, Dirschinger J, Fleck E:
The ECG with coronary angiogram and myocardial scintigraphy for diagnosis of coronary perfusion deficiency.
29th German Congress for Medical Continuing Education, Berlin, 1980

Silber S, Schwaiger M, Klein U, Rudolph W: Comparison of different scintigraphic methods for determining left ventricular ejection fraction. 17th International Annual Meeting of the Society for Nuclear Medicine, Innsbruck, 138, 1979

Silber S, Schwaiger M, Fleck E, Klein U, Rudolph W: Evaluation of the results of a coronary bypass operation using 201-thallium scintigraphy. Journal of Cardiology, 68, 631, 1979

Silber S, Fleck E, Klein U, Rudolph W: Value of 201-thallium stress scintigraphy and exercise ECG in coronary heart disease: comparison of two decision criteria. Journal of Cardiology, 68, 279, 1979

Schwaiger M, Silber S, Klein U, Rudolph W: Non-invasive scintigraphic determination of left ventricular ejection fraction: comparison of different evaluation methods. Journal of Cardiology, 68, 632, 1979

Silber S, Fleck E, Gehrke S, Klein U, Rudolph W: Clinical infarct size determination with 99m-technetium pyrophosphate: correlation with the CK(MB) profile. Journal of Cardiology, Suppl. 5, 152, 1978

Silber S, Fleck E, Bierner M, Jennerwein G, Klein U, Rudolph W: Sensitivity of 201-thallium scintigraphy for the detection of a resolved myocardial infarction. Journal of Cardiology, Suppl. 4, 66, 1977

Klein U, Silber S, Locher D, Rinke H, Goppel L, Rudolph W: 201Thallium scintigraphy in right ventricular pressure and volume overload. 14th International Annual Meeting of the Society for Nuclear Medicine, Berlin, September 15–18, 1976, 73, 1976